Literature DB >> 28923796

Rebound adrenal insufficiency after withdrawal of ritonavir in a 65-year-old man using inhaled budesonide.

Olivier Veilleux1, Todd C Lee1, Emily G McDonald2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28923796      PMCID： PMC5602498          DOI： 10.1503/cmaj.170415

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  Adrenal Insufficiency as a Result of Ritonavir and Exogenous Steroid Exposure: Report of 6 Cases and Recommendation for Management.

Authors:  Brian R Wood; John Matthew Lacy; Christine Johnston; David S Weigle; Shireesha Dhanireddy
Journal:  J Int Assoc Provid AIDS Care       Date:  2015-01-14

2.  Iatrogenic Cushing's syndrome due to coadministration of ritonavir and inhaled budesonide in an asthmatic human immunodeficiency virus infected patient.

Authors:  Eynat Kedem; Eduardo Shahar; Gamal Hassoun; Shimon Pollack
Journal:  J Asthma       Date:  2010-09       Impact factor: 2.515

3.  Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis.

Authors:  B J Lipworth
Journal:  Arch Intern Med       Date:  1999-05-10

4.  Reducing inappropriate polypharmacy: the process of deprescribing.

Authors:  Ian A Scott; Sarah N Hilmer; Emily Reeve; Kathleen Potter; David Le Couteur; Deborah Rigby; Danijela Gnjidic; Christopher B Del Mar; Elizabeth E Roughead; Amy Page; Jesse Jansen; Jennifer H Martin
Journal:  JAMA Intern Med       Date:  2015-05       Impact factor: 21.873

Review 5.  Adrenal suppression and Cushing's syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature.

Authors:  M M Foisy; E M K Yakiwchuk; I Chiu; A E Singh
Journal:  HIV Med       Date:  2008-05-04       Impact factor: 3.180
  5 in total
  4 in total

Review 1.  Managing HIV infection in patients older than 50 years.

Authors:  Jacqueline M McMillan; Hartmut Krentz; M John Gill; David B Hogan
Journal:  CMAJ       Date:  2018-10-22       Impact factor: 8.262

2.  The authors reply to: "Systemic absorption of intranasal corticosteroids may occur and can potentially affect the hypothalamic-pituitary-adrenal axis".

Authors:  Leigh J Sowerby; James Fowler
Journal:  CMAJ       Date:  2021-03-22       Impact factor: 8.262

3.  Systemic absorption of intranasal corticosteroids may occur and can potentially affect the hypothalamic-pituitary-adrenal axis.

Authors:  Gregory A Kline; Christopher J Symonds; Daniel T Holmes
Journal:  CMAJ       Date:  2021-03-22       Impact factor: 8.262

4.  A prospective evaluation on the interaction of fluconazole and voriconazole on serum concentrations of budesonide in patients treated for gastrointestinal GVHD.

Authors:  Thomas E Hughes; Lindsay Stansfield; Parag Kumar; Tat'Yana Worthy; Xin Tian; Richard W Childs
Journal:  Bone Marrow Transplant       Date:  2020-01-17       Impact factor: 5.174
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.